Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Fulgent Genetics reported a quarterly loss of $0.01 per share, beating estimates by 96.97%. - Revenues were $64.49 million, missing estimates by 1.90%. - The stock has underperformed the market, with a Zacks Rank of #3 (Hold). Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Fulgent Genetics reported a quarterly loss of $0.01 per share, beating estimates by 96.97%.
- Revenues were $64.49 million, missing estimates by 1.90%.
- The stock has underperformed the market, with a Zacks Rank of #3 (Hold).
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.